News
The House GOP subcommittee is moving forward with bill crafting despite overwhelming opposition from the public to changing the fundamental structure of Medicare.
For President-elect Joe Biden, creating a public option to compete with private health insurance may be no easier to pass than it was a decade ago. His campaign promise to lower Medicare’s ...
Progressives should embrace an intermediary step between healthcare today and Medicare-for-All. The Public Option is that middle ground. Originally intended to be part of Obamacare, the Public Option ...
Republicans propose Medicare and Medicaid cuts to fund tax breaks under the 'One Big Beautiful Bill Act,' risking voter backlash.
Americans are starting to feel better about the economy. Public sentiment has jumped sharply in the last two months.
The percentage of Americans who think that the education system is going in the “right direction” dropped to 23%, down 10 points from October and 13 points from its peak back in April.
Hosted on MSN27d
Poll: Americans want Social Security, Medicare, Medicaid, food stamps maintained or increasedAlso a federal-state program, Medicare is for people 65 and older, and for the disabled. The poll points to a disconnect between Republicans' policy agenda and public sentiment around the domestic ...
In a turmultuous political landscape, Medicare and Medicaid have experienced both heartbreak and success, from the drama between Florida Gov. Rick Scott (R) and the Obama administration over ...
Public sentiment in Louisiana is showing signs of improvement, according to the 2025 Louisiana Survey released Monday by Louisiana State University. While concerns over the economy, crime, and ...
Democrats have introduced a new bill that would establish a new "Part E" for Medicare that will allow people to opt into the program.
While some federal agency leaders are making headway on their digital transformation projects, according to a recent study from KPMG, there is still room to grow regarding the end-user experience. The ...
The argument that pharmaceutical companies need to charge high prices to invest in research and develop new drugs does little to change that sentiment, according to the new KFF poll. Most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results